The Big Blue Book - 1998 International Family Conference

Disclaimer: This book was created after the 1998 Family Conference.  The articles are important to all of those involved with RTS.  This is online without permission from Dr. Rubinstein and the Cincinnatti Rubinstein-Taybi organization.  They would prefer that you call Dr. Rubinstein at  1-800-344-2462 ext. 4621 and request a copy of the book.  I would encourage everyone, especially those with a child who has RTS to call the above number and request a copy of this book.  I have been reassured by Mark Shannon that this book will be sent to anyone who requests it, regardless of country.
All the information from the book is not online (another reason to call and request the book).  Left out are articles which are copyrighted or are not appropriate for the web site (includes list of attendees).  All articles which are deemed public domain are included..
Diane Wardlow

Behavioral Characteristic of Patients With
Rubinstein-Taybi Syndrome

Poster Session
1998 International Family Conference on Rubinstein-Taybi Syndrome, Cincinnati, Ohio

Ingrid Taff, M.D.; Great Neck, New York
Shirin Z. Madad; Roslyn Harbor, New York

INTRODUCTION

Rubinstein-Taybi syndrome is a genetic syndrome of mental retardation associated with broad thumbs, big toes, characteristic facial appearance with beaked nose, prominent forehead, microcephaly and small maxilla.

The patient seen (in the accompanying video-tape portion of the poster session) presented to the office with multiple manneristic and ritualistic behaviors.  They occurred virtually non-stop and were interfering with his daily functioning.

Little or no information regarding behavioral abnormalities was available; therefore, this study was undertaken to:

  1. Establish the prevalence of the behavioral abnormalities.
  2. Identify the various behavioral deviations.
  3. Investigate usage/efficacy of pharmacological treatments.

MATERIALS AND METHODS

  • A screening questionnaire was sent to 300 families of children with Rubinstein-Taybi syndrome.  We received 152 responses.
  • The questionnaire was geared to identifying autistic-like vehaviors, attention deficit hyperactivity disorder and aggression

CLINICAL VIGNETTE

The patient is a 4-2/3 year old youngster with Rubinstein-Taybi syndrome.  He developed severe manneristic and ritualistic behavior at around the age of two as documented on the videotape.  These behaviors escalated at around the age of three and have persisted to date.  The patient is in an intervention program receiving occupational therapy programming, receiving sensory integration and vestibular stimulation.  His cognitive progress has been slow.

Prior to starting any pharmacological approach for these behaviors, a MRI of the brain was obtained; no cerebral abnormality was found.  The patient did have evidence of mastoid disease.  Treatment for this condition (decongestants and antibiotics) did not change the mannerisms.  Over the past eighteen months, the following medications have been tried:

  • Combination of magnesium, vitamin B-6 and Dimethylglycine
  • Prozac (up to 3 c per day)
  • Periactin (up to 1 teaspoon three times daily)
  • Inositol
  • Antivert
  • Ritalin

No significant change was seen in the rituals/mannerisms but Ritalin improved his attention span and made him less motor restless.  Any suggestions for a possible treatment would be welcomed.

RESULTS

The results of the questionnaire are as follows:

  • 4.5% of the children were female
  • 54.5% were male
  • 77% of the children had repetitive motions such as flapping, spinning, etc.
  • 68% were resistant to change
  • 56.8% had an abnormal response to pain
  • 48.5% had poor eye contact
  • 40.9% were preoccupied with smelling, tasting, and feeling objects
  • 72.7% of the children were distractible
  • 56.8% had aggressive outbursts
  • At least 1/4 had abnormal use of objects, excessive fears, difficulties relating to others and visual scrutiny
  • 21% of the children had trouble sleeping
  • 95 were on astimulant medication, but surprisingly, few RTS patients were treated with Selective Serotonin-Reuptake Inhibitors (SSRIs), anti-psychotics or anti-anxiety drugs.

CONCLUSION

Behavior abnormalities in Rubinstein-Taybi patients are more common and debilitating than was previously reported.  To our knowledge, this survey represents the largest investigation of its kind.  It appears that no specific therapeutic approach has been established.

In view of this significant prevalence of behavioral difficulties and the tremendous burden this problem places on the parents (as evidenced by the responses on the questionnaire), we feel that additional investigation is warranted, with special focus on specific treatment.

Proceedings

Rubinstein-Taybi.org Site

Replication:
This information is in the public domain unless otherwise indicated.  Readers are encouraged to copy and share it, but please credit The Proceedings for the 1998 International Family Conference on Rubinstein-Taybi Syndrome.

Funding:
UACCDD receives major support from the Hamilton County Mental Retardation Service Levy.  Additional funding sources include: United Way and Community Chest; Maternal and Child Health Bureau and the Administration on Developmental Disabilities of the Department of Health and Human Services; other county, state, and federal agencies; foundations; and individual contributions.
The 1998 International Family Conference on Rubinstein-Taybi Syndrome is very grateful for the generous support of The Special Friends Foundation
.

This document was added to the Rubinstein-Taybi web site in November 2000.

If any of the information found on this website does not adhere to copyright laws it is unintentional, please contact dwardlow@uswest.net and it will be removed from the site.

http://www.rubinstein-taybi.org